Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

IO Biotech (IOBT) Institutional Ownership

IO Biotech logo
$1.74 -0.03 (-1.69%)
Closing price 04:00 PM Eastern
Extended Trading
$1.75 +0.01 (+0.57%)
As of 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for IO Biotech (NASDAQ:IOBT)

Current
Institutional Ownership
Percentage
54.76%
Number of
Institutional Buyers
(last 12 months)
9
Total
Institutional Inflows
(last 12 months)
$1.57M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$1.38M
Get IOBT Insider Trade Alerts

Want to know when executives and insiders are buying or selling IO Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

IOBT Institutional Buying and Selling by Quarter

IO Biotech Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/19/2025 Marex Group plc45,000$63K0.0%N/A0.000%
8/15/2025 Bank of America Corp DE1,615,074$2.25M0.0%-2.2%0.000%
8/14/2025 NewEdge Advisors LLC24,217$34K0.0%N/A0.037%
8/12/2025 XTX Topco Ltd29,189$41K0.0%-42.2%0.000%
5/21/2025 Acadian Asset Management LLC30,858$33K0.0%-49.1%0.047%
5/19/2025 Jane Street Group LLC23,717$26K0.0%N/A0.036%
5/15/2025 Landscape Capital Management L.L.C.400,234$436K0.0%-9.5%0.608%
5/8/2025 XTX Topco Ltd50,486$55K0.0%+80.0%0.077%
5/7/2025 Dauntless Investment Group LLC681,446$743K0.9%-8.9%1.034%
2/17/2025 Bridgeway Capital Management LLC174,000$160K0.0%-12.8%0.264%
2/17/2025 Citadel Advisors LLC270,504$249K0.0%N/A0.411%
2/14/2025 Dauntless Investment Group LLC747,646$688K0.7%N/A1.135%
2/13/2025 XTX Topco Ltd28,040$26K0.0%N/A0.043%
2/13/2025 Renaissance Technologies LLC118,800$109K0.0%+22.5%0.180%
2/12/2025 Landscape Capital Management L.L.C.442,196$407K0.0%N/A0.671%
1/30/2025 Vontobel Holding Ltd.32,667$30K0.0%N/A0.050%
10/24/2024 Novo Holdings A S3,354,449$3.52M0.2%-24.3%5.092%
8/20/2024 Novo Holdings A S4,429,449$5.18M0.3%-12.9%6.723%
8/15/2024 Armistice Capital LLC1,545,000$1.81M0.0%-10.4%2.345%
8/12/2024 XTX Topco Ltd26,555$31K0.0%+67.4%0.040%
8/9/2024 Renaissance Technologies LLC180,800$212K0.0%+8.1%0.274%
2/15/2024 PFM Health Sciences LP2,341,107$4.40M0.3%+73.0%3.554%
2/13/2024 Stonepine Capital Management LLC1,666,037$3.13M1.4%-15.7%2.529%
2/13/2024 Armistice Capital LLC1,924,000$3.62M0.0%-10.4%2.920%
11/15/2023 Armistice Capital LLC2,148,000$3.03M0.0%N/A3.260%
11/14/2023 Stonepine Capital Management LLC1,975,308$2.79M0.9%N/A2.998%
11/14/2023 Pivotal bioVenture Partners Investment Advisor LLC864,197$1.22M0.5%N/A1.312%
11/8/2023 Vivo Capital LLC6,173,439$8.71M1.1%+104.7%9.371%
7/25/2023 Summit Trail Advisors LLC43,744$86K0.0%N/A0.152%
2/14/2023 RA Capital Management L.P.1,127,260$2.59M0.1%-39.3%3.911%
11/14/2022Psagot Value Holdings Ltd. Israel40,846$111K0.0%N/A0.142%
11/2/2022 Victory Capital Management Inc.43,741$119K0.0%N/A0.152%
2/15/2022 Samsara BioCapital LLC1,120,437$7.17M1.4%N/A3.888%
2/15/2022 Capital World Investors1,235,000$8.11M0.0%N/A4.286%
2/14/2022 Soleus Capital Management L.P.672,734$4.31M0.4%N/A2.335%
2/14/2022 Novo Holdings A S3,277,932$20.98M1.0%N/A11.376%
(Data available from 1/1/2016 forward)

IOBT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IOBT shares?

During the previous two years, 18 institutional investors and hedge funds held shares of IO Biotech. The most heavily invested institutionals were Vivo Capital LLC ($8.71M), PFM Health Sciences LP ($4.40M), Novo Holdings A S ($3.52M), Stonepine Capital Management LLC ($3.13M), Bank of America Corp DE ($2.25M), Armistice Capital LLC ($1.81M), and Pivotal bioVenture Partners Investment Advisor LLC ($1.22M).Learn more on IO Biotech's institutional investors.

What percentage of IO Biotech's stock is owned by institutional investors?

54.76% of IO Biotech's stock is owned by institutional investors. Learn more on IOBT's institutional investor holdings.

Which institutional investors have been buying IO Biotech's stock?

Of the 14 institutional investors that purchased IO Biotech's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($3.16M), Armistice Capital LLC ($2.15M), Stonepine Capital Management LLC ($1.98M), PFM Health Sciences LP ($987.65K), Pivotal bioVenture Partners Investment Advisor LLC ($864.20K), Dauntless Investment Group LLC ($747.65K), and Landscape Capital Management L.L.C. ($442.20K).

How much institutional buying is happening at IO Biotech?

Institutional investors have bought a total of 1,658,233 shares in the last 24 months. This purchase volume represents approximately $1.57M in transactions.

Which of IO Biotech's major shareholders have been selling company stock?

The following institutional investors have sold IO Biotech stock in the last 24 months: Novo Holdings A S ($1.08M), Dauntless Investment Group LLC ($66.20K), Landscape Capital Management L.L.C. ($41.96K), Bank of America Corp DE ($36.44K), Acadian Asset Management LLC ($29.79K), Bridgeway Capital Management LLC ($25.62K), and XTX Topco Ltd ($21.30K).

How much institutional selling is happening at IO Biotech?

Institutional investors have sold a total of 1,296,315 shares in the last 24 months. This volume of shares sold represents approximately $1.38M in transactions.


Related Companies

This page (NASDAQ:IOBT) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Elon Musk’s New Technology
Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...
Paradigm Press | Sponsoredtc pixel
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
The stealth altcoin the financial world is underestimating
This DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...
Crypto 101 Media | Sponsoredtc pixel
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsoredtc pixel
A grave, grave error.
Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...
Porter & Company | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel